Theravance Biopharma Inc (TBPH)
Operating Income Growth
112.52%
TTM · Period ending:
TBPH Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported112.52%period ending
Latest reported112.52%period ending
TBPH TTM Operating Income YoY % (-51.90% → 112.52%)
Year-over-year change
High-resolution chart · PNG
TBPH operating income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Income Growth |
|---|---|
| 112.5175% | |
| 105.0522% | |
| 87.1158% | |
| 25.4041% | |
| 11.2521% | |
| -18.5353% | |
| 16.2149% | |
| 34.5655% | |
| 42.324% | |
| 46.8523% | |
| 39.0639% | |
| 48.5619% | |
| 57.2808% | |
| 62.2736% | |
| 64.3279% | |
| 53.0062% | |
| 43.5065% | |
| 31.7162% | |
| 13.4247% | |
| 4.7053% | |
| -7.3752% | |
| -23.3116% | |
| -18.1974% | |
| -19.6238% | |
| -16.2562% | |
| -1.3272% | |
| -5.5137% | |
| 4.4425% | |
| 3.458% | |
| 7.0714% | |
| 8.2161% | |
| -6.9206% | |
| -16.0606% | |
| -34.7152% | |
| -44.1388% | |
| -33.8406% | |
| -14.5047% | |
| -6.3777% | |
| 0.7873% | |
| 7.0206% | |
| 5.45% | |
| 11.6305% | |
| 21.777% | |
| 9.0048% | |
| 1.5043% | |
| -14.1912% | |
| -48.7926% | |
| -49.1421% | |
| -51.9018% |